CLOV Stock Risk & Deep Value Analysis

Clover Health Investments Corp

DVR Score

3.9

out of 10

Risk Trap

What You Need to Know About CLOV Stock

We analyzed Clover Health Investments Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran CLOV through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated Mar 14, 2026•Run Fresh Analysis →

How Risky Is CLOV Stock?

Overall Risk

Aggressive

Financial Risk

High

Market Risk

Medium

Competitive Risk

High

Execution Risk

High

Regulatory Risk

High

What Are the Red Flags for CLOV?

  • âš 

    Higher-than-expected Medical Care Ratio (MCR) in upcoming earnings reports.

  • âš 

    Adverse regulatory changes impacting Medicare Advantage reimbursement or operations.

  • âš 

    Continued cash burn leading to further equity dilution or debt financing at unfavorable terms.

  • âš 

    Increased competitive pressure from larger, well-funded incumbents.

Unlock CLOV Red Flags & Risk Warnings

Create a free account to see the full analysis

Is CLOV Stock Undervalued?

Clover Health continues its disciplined turnaround, showing sustained progress in financial stability, notably via MCR improvement and cash management. This operational rigor reduces near-term risks and showcases leadership adaptability within the challenging Medicare Advantage sector. However, the path to 10x growth within 3-5 years remains highly speculative. A robust, defensible competitive moat against well-established incumbents is largely unproven, and intense market competition coupled with persistent regulatory hurdles continues to restrict potential for explosive market share gains. While foundational stabilization is evident and slightly improved, a clear, validated strategy for truly disruptive, multi-bagger growth is still in its nascent stages, preventing a significant re-rating towards 10x potential.

Unlock the full AI analysis for CLOV

Get the complete DVR score, risk analysis, and more

Does CLOV Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

Stable

Moat Sources

2 Identified

Intangible Assets/IP (Clover Assistant software)Switching Costs (for integrated physician practices)

Clover's moat is nascent and relies heavily on the unique capabilities and adoption of Clover Assistant. Its durability is uncertain as larger competitors possess significant resources to develop or acquire similar technologies, and regulatory changes could impact its operating model.

Moat Erosion Risks

  • •Scalability challenges for Clover Assistant to reach critical mass and generate network effects.
  • •Competitors developing or acquiring similar or superior AI-driven care platforms.
  • •Regulatory changes that could undermine the value proposition of tech-enabled MA plans.

CLOV Competitive Moat Analysis

Sign up to see competitive advantages

What Could Drive CLOV Stock Higher?

Near-Term (0-6 months)

  • •Q1 2026 Earnings Report (Estimated Early May 2026), focusing on continued MCR improvement and cash flow.
  • •Updates on Clover Assistant adoption rates and efficacy data within physician networks.

Medium-Term (6-18 months)

  • •Announcement of 2027 Medicare Advantage plan offerings and pricing, indicating competitive positioning.
  • •Potential new market entries or expansion of existing service areas for Medicare Advantage plans.
  • •Significant partnerships with healthcare providers or technology integrators.

Long-Term (18+ months)

  • •Sustained, consistent profitability and positive free cash flow generation.
  • •Disruption of traditional Medicare Advantage models through technology-driven cost efficiencies.
  • •Significant increase in market share driven by superior patient outcomes and lower costs.

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for CLOV?

  • ✓

    Consistent quarter-over-quarter improvement in Medical Care Ratio (MCR).

  • ✓

    Positive free cash flow generation and reduced reliance on external funding.

  • ✓

    Accelerated growth in membership, particularly in direct contracting or higher-margin plans.

  • ✓

    Clear evidence of expanding competitive advantages through Clover Assistant adoption and impact.

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CLOV (Clover Health Investments Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More
Navigated to CLOV Stock Risk & Deep Value Analysis